Form D · Biotechnology
Abpro Corp
Woburn, MA · CIK 0001670356
Offering snapshot reported Apr 6, 2022 · SEC filing
- Reported sold
- $2M Offering amount: $80M
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Mar 30, 2022 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Apr 6, 2022 | Initial | $1,999,998 | No comparison | 1 | SEC filing |
| Jan 28, 2020 | Initial | $17,999,992 | No comparison | 1 | SEC filing |
| Apr 7, 2017 | Initial | $9,999,990 | No comparison | 1 | SEC filing |
| Mar 24, 2016 | Initial | $12,389,994 | No comparison | 7 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-440631
Source: Form D, filed Apr 6, 2022. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Eugene Chan | Director, Executive |
| Ian Chan | Director, Executive |
| Kevin Comerford | Executive |
| Benjamin Ha | Director |
| Robert Langer | Director |
| Adam S. Mostafa | Executive |
| Shengxin Qin | Director |
| Miles Suk | Director |
| Mark Tang | Director |
| Thomas Weng | Director |
| Feng Ye | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
68 Cummings Park Drive
Woburn, MA, 01801
Woburn, MA, 01801